Values First Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Buy
44,241
+298
+0.7% +$7.28K 0.55% 57
2025
Q4
$994K Sell
43,943
-9,224
-17% -$201K 0.52% 62
2025
Q3
$1.07M Sell
53,167
-1,012
-2% -$17K 0.57% 55
2025
Q2
$774K Buy
54,179
+25,766
+91% +$301K 0.42% 68
2025
Q1
$298K Sell
28,413
-85
-0.3% -$962 0.17% 141
2024
Q4
$345K Sell
28,498
-6,382
-18% -$83.5K 0.19% 130
2024
Q3
$512K Sell
34,880
-657
-2% -$9.15K 0.28% 90
2024
Q2
$513K Sell
35,537
-220
-0.6% -$3.52K 0.31% 82
2024
Q1
$582K Sell
35,757
-164
-0.5% -$2.56K 0.34% 85
2023
Q4
$535K Buy
35,921
+3,239
+10% +$36.7K 0.32% 91
2023
Q3
$367K Sell
32,682
-251
-0.8% -$2.92K 0.24% 110
2023
Q2
$331K Buy
32,933
+683
+2% +$6.34K 0.2% 121
2023
Q1
$303K Buy
+32,250
New +$380K 0.19% 116

Other funds holding ELAN

Values First Advisors's ELAN Position: Q1 2026 in Review

Values First Advisors increased its Elanco Animal Health (ELAN) stake by 0.68% in Q1 2026, buying an estimated $7.28K and bringing the position to 44,241 shares worth $1.06M. The position accounts for 0.55% of the portfolio, ranked #57.

Values First Advisors first reported a position in ELAN in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.07M in Q3 2025. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Values First Advisors held 44,241 shares of Elanco Animal Health worth $1.06M as of Q1 2026.
  • Values First Advisors bought 298 Elanco Animal Health shares in Q1 2026, an estimated $7.28K.
  • Elanco Animal Health made up 0.55% of Values First Advisors's portfolio in Q1 2026, its #57 holding.
  • Values First Advisors first reported a position in Elanco Animal Health in Q1 2023 and has held it in 13 quarters since.
  • Values First Advisors's Elanco Animal Health position peaked at $1.07M in Q3 2025.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.